Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

The Stay-At-Home Apocalypse
  • Market outlook

The Stay-At-Home Apocalypse

It was a wild day on the markets on Monday thanks to the revelation from Pfizer that their experimental COVID-19 vaccine was more than 90% effective in phase three tests. Though this doesn’t mean we’re out of the woods just yet, it does indicate that a vaccine might come available sooner rather than later, with Pfizer Chairman and CEO Dr. Albert Bourla calling it “a great day for science and humanity.”

This article was originally published on MyWallSt — Investing Is for Everyone. We Show You How to Succeed.

 

Not all smiles

However, it wasn’t all smiles for some, with shares in teleconferencing leader, Zoom, absolutely cratering off the back of Pfizer’s announcement.

Of course, we could have easily picked some of our other ‘stay-at-home’ stocks that got hit hard either, like Peloton (-20.3%), 2U Inc (-20.5%), or Etsy (-17.1%). Conversely, some of the companies that have been most affected by the pandemic had their best day in a long time, including Eventbrite (+32.2%), Wynn Resorts (+27.7%), and Nordstrom (+25.9%).

Basically, the market decided yesterday that the pandemic was over and everyone could leave their homes immediately. So should our investing plans change now that we might have COVID-19 on the back foot?

 

Not so fast

To wheel out an overused phrase once more, “These are unprecedented times we are living in.” The global landscape has shifted enormously in the last twelve months and, even if a fully-effective vaccine were to be rolled out to every person in the world tomorrow, the world won’t just simply go back to the way things were.

Take e-commerce penetration, for example, which is expected to grow by more than 30% this year alone — accelerating the shift to online two years faster than expected. Do you think you’ll use Amazon less once local stores reopen?

Or what about the fact that most major tech firms have already told their employees that they will not be expected to return to the office until summer 2021. It’s hard to see management reneging on that decision, whatever may happen over the next few months. Indeed, many companies like Dropbox, Microsoft, Twitter, and Square have all decided that employees need never return to the office if they wish.

Or take Peloton’s most recent earnings call, where management said that they simply weren’t able to keep up with the demand for their products. Do you think all of those customers will let their bikes become $2,500 clothes racks and go back to sweaty, overcrowded gyms?

In the madness of yesterday’s market, MyWallSt head analyst Rory Carron tweeted: “Today of all days, don’t make major decisions on headlines.” Certainly, Pfizer’s announcement is fantastic news that gives us all some much-needed light at the end of the tunnel, but don’t expect things to go back to the way they are.

If you’ve been looking at those pandemic-fuelled stocks like Shopify, Zoom, and Peloton wistfully over the past few months thinking of what could have been, now might be your chance to put your money where your mouth is.

 

MyWallSt makes it easy for you to pick winning stocks. Start your free trial with us today— it's the best investment you'll ever make.

 

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles